 
                Peter Gennemark
Adjunct Associate Professor, Docent
My research aims to improve understanding of diabetes and cardiovascular disease and their treatment, by mathematical modelling.
Systems pharmacology – a pharma industry collaboration
                    Peter Gennemark (Principal scientist at AstraZeneca, Gothenburg, Sweden) is adjunct senior lecturer at IMT. Peter has an established collaboration in systems pharmacology with Gunnar Cedersund (IMT). His research is directed towards systems pharmacology in the diabetes and cardiovascular disease areas, with the aim of increasing knowledge of biology, disease progression and drug intervention in these areas.
                
            Publications
2025
 Continue to DOI
                                                    Continue to DOI
                                                
                                            
                                    
                            2024
 Continue to DOI
                                                    Continue to DOI
                                                
                                            
                                    
                             Continue to DOI
                                                    Continue to DOI
                                                
                                            
                                    
                             Continue to DOI
                                                    Continue to DOI
                                                
                                            
                                    
                             Continue to DOI
                                                    Continue to DOI